Claudia Wagner

Claudia Wagner

Company: Immatics

Job title: Senior Director, Immunology, Head of TCR Discovery & Validation

Seminars:

Advancing Development of TCR-T Cell Therapy Alongside TCR Bispecifics Modalities 3:45 pm

Discovery and validation of TCR molecules suited to adoptive cell therapy of bispecific modalities Distinguishing attributes of each TCR modality to identify advantages and areas of strength Sharing insights from the clinical ACTengine® trialRead more

day: Conference Day One

Panel: Comparing the Characteristics of TCR-T Cell Therapies & TCR Bispecifics (& More!) to Reaffirm their Unique Benefits 2:00 pm

Comparing relative affinities, potencies and safety considerations of T-cell therapies and bispecifics Assessing indications and patients where each TCR modality could be best suited to treat What other modalities can TCR therapies venture into in the future?Read more

day: Conference Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.